Global Drug Eluting Stents (DES) Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Drug Eluting Stents (DES) Market Size was estimated at USD 1566.43 million in 2023 and is projected to reach USD 2430.99 million by 2029, exhibiting a CAGR of 7.60% during the forecast period.
This report provides a deep insight into the global Drug Eluting Stents (DES) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Eluting Stents (DES) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Eluting Stents (DES) market in any manner.
Global Drug Eluting Stents (DES) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market Segmentation (by Type)
s
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Market Segmentation (by Application)
Coronary Heart Disease
Clinical
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Eluting Stents (DES) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Drug Eluting Stents (DES) Market Size was estimated at USD 1566.43 million in 2023 and is projected to reach USD 2430.99 million by 2029, exhibiting a CAGR of 7.60% during the forecast period.
This report provides a deep insight into the global Drug Eluting Stents (DES) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Eluting Stents (DES) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Eluting Stents (DES) market in any manner.
Global Drug Eluting Stents (DES) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market Segmentation (by Type)
s
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Market Segmentation (by Application)
Coronary Heart Disease
Clinical
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug Eluting Stents (DES) Market
- Overview of the regional outlook of the Drug Eluting Stents (DES) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Eluting Stents (DES) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug Eluting Stents (DES)
1.2 Key Market Segments
1.2.1 Drug Eluting Stents (DES) Segment by Type
1.2.2 Drug Eluting Stents (DES) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG ELUTING STENTS (DES) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug Eluting Stents (DES) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug Eluting Stents (DES) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG ELUTING STENTS (DES) MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug Eluting Stents (DES) Sales by Manufacturers (2019-2024)
3.2 Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug Eluting Stents (DES) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug Eluting Stents (DES) Sales Sites, Area Served, Product Type
3.6 Drug Eluting Stents (DES) Market Competitive Situation and Trends
3.6.1 Drug Eluting Stents (DES) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug Eluting Stents (DES) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG ELUTING STENTS (DES) INDUSTRY CHAIN ANALYSIS
4.1 Drug Eluting Stents (DES) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG ELUTING STENTS (DES) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Eluting Stents (DES) Sales Market Share by Type (2019-2024)
6.3 Global Drug Eluting Stents (DES) Market Size Market Share by Type (2019-2024)
6.4 Global Drug Eluting Stents (DES) Price by Type (2019-2024)
7 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Eluting Stents (DES) Market Sales by Application (2019-2024)
7.3 Global Drug Eluting Stents (DES) Market Size (M USD) by Application (2019-2024)
7.4 Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2019-2024)
8 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY REGION
8.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.2 Global Drug Eluting Stents (DES) Sales Market Share by Region
8.2 North America
8.2.1 North America Drug Eluting Stents (DES) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Eluting Stents (DES) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Eluting Stents (DES) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Eluting Stents (DES) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Eluting Stents (DES) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Vascular
9.1.1 Abbott Vascular Drug Eluting Stents (DES) Basic Information
9.1.2 Abbott Vascular Drug Eluting Stents (DES) Product Overview
9.1.3 Abbott Vascular Drug Eluting Stents (DES) Product Market Performance
9.1.4 Abbott Vascular Business Overview
9.1.5 Abbott Vascular Drug Eluting Stents (DES) SWOT Analysis
9.1.6 Abbott Vascular Recent Developments
9.2 Advantec Vascular
9.2.1 Advantec Vascular Drug Eluting Stents (DES) Basic Information
9.2.2 Advantec Vascular Drug Eluting Stents (DES) Product Overview
9.2.3 Advantec Vascular Drug Eluting Stents (DES) Product Market Performance
9.2.4 Advantec Vascular Business Overview
9.2.5 Advantec Vascular Drug Eluting Stents (DES) SWOT Analysis
9.2.6 Advantec Vascular Recent Developments
9.3 B.Braun Melsengen AG
9.3.1 B.Braun Melsengen AG Drug Eluting Stents (DES) Basic Information
9.3.2 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
9.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Market Performance
9.3.4 B.Braun Melsengen AG Drug Eluting Stents (DES) SWOT Analysis
9.3.5 B.Braun Melsengen AG Business Overview
9.3.6 B.Braun Melsengen AG Recent Developments
9.4 Biosensors
9.4.1 Biosensors Drug Eluting Stents (DES) Basic Information
9.4.2 Biosensors Drug Eluting Stents (DES) Product Overview
9.4.3 Biosensors Drug Eluting Stents (DES) Product Market Performance
9.4.4 Biosensors Business Overview
9.4.5 Biosensors Recent Developments
9.5 Biotronik
9.5.1 Biotronik Drug Eluting Stents (DES) Basic Information
9.5.2 Biotronik Drug Eluting Stents (DES) Product Overview
9.5.3 Biotronik Drug Eluting Stents (DES) Product Market Performance
9.5.4 Biotronik Business Overview
9.5.5 Biotronik Recent Developments
9.6 Blue Medical
9.6.1 Blue Medical Drug Eluting Stents (DES) Basic Information
9.6.2 Blue Medical Drug Eluting Stents (DES) Product Overview
9.6.3 Blue Medical Drug Eluting Stents (DES) Product Market Performance
9.6.4 Blue Medical Business Overview
9.6.5 Blue Medical Recent Developments
9.7 Boston Scientific
9.7.1 Boston Scientific Drug Eluting Stents (DES) Basic Information
9.7.2 Boston Scientific Drug Eluting Stents (DES) Product Overview
9.7.3 Boston Scientific Drug Eluting Stents (DES) Product Market Performance
9.7.4 Boston Scientific Business Overview
9.7.5 Boston Scientific Recent Developments
9.8 DISA Vascular
9.8.1 DISA Vascular Drug Eluting Stents (DES) Basic Information
9.8.2 DISA Vascular Drug Eluting Stents (DES) Product Overview
9.8.3 DISA Vascular Drug Eluting Stents (DES) Product Market Performance
9.8.4 DISA Vascular Business Overview
9.8.5 DISA Vascular Recent Developments
9.9 Essen
9.9.1 Essen Drug Eluting Stents (DES) Basic Information
9.9.2 Essen Drug Eluting Stents (DES) Product Overview
9.9.3 Essen Drug Eluting Stents (DES) Product Market Performance
9.9.4 Essen Business Overview
9.9.5 Essen Recent Developments
9.10 Medtronic Vascular
9.10.1 Medtronic Vascular Drug Eluting Stents (DES) Basic Information
9.10.2 Medtronic Vascular Drug Eluting Stents (DES) Product Overview
9.10.3 Medtronic Vascular Drug Eluting Stents (DES) Product Market Performance
9.10.4 Medtronic Vascular Business Overview
9.10.5 Medtronic Vascular Recent Developments
9.11 MicroPort Medical
9.11.1 MicroPort Medical Drug Eluting Stents (DES) Basic Information
9.11.2 MicroPort Medical Drug Eluting Stents (DES) Product Overview
9.11.3 MicroPort Medical Drug Eluting Stents (DES) Product Market Performance
9.11.4 MicroPort Medical Business Overview
9.11.5 MicroPort Medical Recent Developments
9.12 MIV Therapeutics
9.12.1 MIV Therapeutics Drug Eluting Stents (DES) Basic Information
9.12.2 MIV Therapeutics Drug Eluting Stents (DES) Product Overview
9.12.3 MIV Therapeutics Drug Eluting Stents (DES) Product Market Performance
9.12.4 MIV Therapeutics Business Overview
9.12.5 MIV Therapeutics Recent Developments
9.13 Orbusneich
9.13.1 Orbusneich Drug Eluting Stents (DES) Basic Information
9.13.2 Orbusneich Drug Eluting Stents (DES) Product Overview
9.13.3 Orbusneich Drug Eluting Stents (DES) Product Market Performance
9.13.4 Orbusneich Business Overview
9.13.5 Orbusneich Recent Developments
9.14 Promed Medical
9.14.1 Promed Medical Drug Eluting Stents (DES) Basic Information
9.14.2 Promed Medical Drug Eluting Stents (DES) Product Overview
9.14.3 Promed Medical Drug Eluting Stents (DES) Product Market Performance
9.14.4 Promed Medical Business Overview
9.14.5 Promed Medical Recent Developments
9.15 Relisys Medical
9.15.1 Relisys Medical Drug Eluting Stents (DES) Basic Information
9.15.2 Relisys Medical Drug Eluting Stents (DES) Product Overview
9.15.3 Relisys Medical Drug Eluting Stents (DES) Product Market Performance
9.15.4 Relisys Medical Business Overview
9.15.5 Relisys Medical Recent Developments
9.16 Reva Medical
9.16.1 Reva Medical Drug Eluting Stents (DES) Basic Information
9.16.2 Reva Medical Drug Eluting Stents (DES) Product Overview
9.16.3 Reva Medical Drug Eluting Stents (DES) Product Market Performance
9.16.4 Reva Medical Business Overview
9.16.5 Reva Medical Recent Developments
9.17 Sahajanand
9.17.1 Sahajanand Drug Eluting Stents (DES) Basic Information
9.17.2 Sahajanand Drug Eluting Stents (DES) Product Overview
9.17.3 Sahajanand Drug Eluting Stents (DES) Product Market Performance
9.17.4 Sahajanand Business Overview
9.17.5 Sahajanand Recent Developments
9.18 Sino Medical
9.18.1 Sino Medical Drug Eluting Stents (DES) Basic Information
9.18.2 Sino Medical Drug Eluting Stents (DES) Product Overview
9.18.3 Sino Medical Drug Eluting Stents (DES) Product Market Performance
9.18.4 Sino Medical Business Overview
9.18.5 Sino Medical Recent Developments
9.19 Sorin
9.19.1 Sorin Drug Eluting Stents (DES) Basic Information
9.19.2 Sorin Drug Eluting Stents (DES) Product Overview
9.19.3 Sorin Drug Eluting Stents (DES) Product Market Performance
9.19.4 Sorin Business Overview
9.19.5 Sorin Recent Developments
9.20 Terumo Medical
9.20.1 Terumo Medical Drug Eluting Stents (DES) Basic Information
9.20.2 Terumo Medical Drug Eluting Stents (DES) Product Overview
9.20.3 Terumo Medical Drug Eluting Stents (DES) Product Market Performance
9.20.4 Terumo Medical Business Overview
9.20.5 Terumo Medical Recent Developments
10 DRUG ELUTING STENTS (DES) MARKET FORECAST BY REGION
10.1 Global Drug Eluting Stents (DES) Market Size Forecast
10.2 Global Drug Eluting Stents (DES) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Eluting Stents (DES) Market Size Forecast by Country
10.2.3 Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region
10.2.4 South America Drug Eluting Stents (DES) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Eluting Stents (DES) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug Eluting Stents (DES) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug Eluting Stents (DES) by Type (2025-2030)
11.1.2 Global Drug Eluting Stents (DES) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug Eluting Stents (DES) by Type (2025-2030)
11.2 Global Drug Eluting Stents (DES) Market Forecast by Application (2025-2030)
11.2.1 Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application
11.2.2 Global Drug Eluting Stents (DES) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug Eluting Stents (DES)
1.2 Key Market Segments
1.2.1 Drug Eluting Stents (DES) Segment by Type
1.2.2 Drug Eluting Stents (DES) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG ELUTING STENTS (DES) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug Eluting Stents (DES) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug Eluting Stents (DES) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG ELUTING STENTS (DES) MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug Eluting Stents (DES) Sales by Manufacturers (2019-2024)
3.2 Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug Eluting Stents (DES) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug Eluting Stents (DES) Sales Sites, Area Served, Product Type
3.6 Drug Eluting Stents (DES) Market Competitive Situation and Trends
3.6.1 Drug Eluting Stents (DES) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug Eluting Stents (DES) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG ELUTING STENTS (DES) INDUSTRY CHAIN ANALYSIS
4.1 Drug Eluting Stents (DES) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG ELUTING STENTS (DES) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Eluting Stents (DES) Sales Market Share by Type (2019-2024)
6.3 Global Drug Eluting Stents (DES) Market Size Market Share by Type (2019-2024)
6.4 Global Drug Eluting Stents (DES) Price by Type (2019-2024)
7 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Eluting Stents (DES) Market Sales by Application (2019-2024)
7.3 Global Drug Eluting Stents (DES) Market Size (M USD) by Application (2019-2024)
7.4 Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2019-2024)
8 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY REGION
8.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.2 Global Drug Eluting Stents (DES) Sales Market Share by Region
8.2 North America
8.2.1 North America Drug Eluting Stents (DES) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Eluting Stents (DES) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Eluting Stents (DES) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Eluting Stents (DES) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Eluting Stents (DES) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Vascular
9.1.1 Abbott Vascular Drug Eluting Stents (DES) Basic Information
9.1.2 Abbott Vascular Drug Eluting Stents (DES) Product Overview
9.1.3 Abbott Vascular Drug Eluting Stents (DES) Product Market Performance
9.1.4 Abbott Vascular Business Overview
9.1.5 Abbott Vascular Drug Eluting Stents (DES) SWOT Analysis
9.1.6 Abbott Vascular Recent Developments
9.2 Advantec Vascular
9.2.1 Advantec Vascular Drug Eluting Stents (DES) Basic Information
9.2.2 Advantec Vascular Drug Eluting Stents (DES) Product Overview
9.2.3 Advantec Vascular Drug Eluting Stents (DES) Product Market Performance
9.2.4 Advantec Vascular Business Overview
9.2.5 Advantec Vascular Drug Eluting Stents (DES) SWOT Analysis
9.2.6 Advantec Vascular Recent Developments
9.3 B.Braun Melsengen AG
9.3.1 B.Braun Melsengen AG Drug Eluting Stents (DES) Basic Information
9.3.2 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
9.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Market Performance
9.3.4 B.Braun Melsengen AG Drug Eluting Stents (DES) SWOT Analysis
9.3.5 B.Braun Melsengen AG Business Overview
9.3.6 B.Braun Melsengen AG Recent Developments
9.4 Biosensors
9.4.1 Biosensors Drug Eluting Stents (DES) Basic Information
9.4.2 Biosensors Drug Eluting Stents (DES) Product Overview
9.4.3 Biosensors Drug Eluting Stents (DES) Product Market Performance
9.4.4 Biosensors Business Overview
9.4.5 Biosensors Recent Developments
9.5 Biotronik
9.5.1 Biotronik Drug Eluting Stents (DES) Basic Information
9.5.2 Biotronik Drug Eluting Stents (DES) Product Overview
9.5.3 Biotronik Drug Eluting Stents (DES) Product Market Performance
9.5.4 Biotronik Business Overview
9.5.5 Biotronik Recent Developments
9.6 Blue Medical
9.6.1 Blue Medical Drug Eluting Stents (DES) Basic Information
9.6.2 Blue Medical Drug Eluting Stents (DES) Product Overview
9.6.3 Blue Medical Drug Eluting Stents (DES) Product Market Performance
9.6.4 Blue Medical Business Overview
9.6.5 Blue Medical Recent Developments
9.7 Boston Scientific
9.7.1 Boston Scientific Drug Eluting Stents (DES) Basic Information
9.7.2 Boston Scientific Drug Eluting Stents (DES) Product Overview
9.7.3 Boston Scientific Drug Eluting Stents (DES) Product Market Performance
9.7.4 Boston Scientific Business Overview
9.7.5 Boston Scientific Recent Developments
9.8 DISA Vascular
9.8.1 DISA Vascular Drug Eluting Stents (DES) Basic Information
9.8.2 DISA Vascular Drug Eluting Stents (DES) Product Overview
9.8.3 DISA Vascular Drug Eluting Stents (DES) Product Market Performance
9.8.4 DISA Vascular Business Overview
9.8.5 DISA Vascular Recent Developments
9.9 Essen
9.9.1 Essen Drug Eluting Stents (DES) Basic Information
9.9.2 Essen Drug Eluting Stents (DES) Product Overview
9.9.3 Essen Drug Eluting Stents (DES) Product Market Performance
9.9.4 Essen Business Overview
9.9.5 Essen Recent Developments
9.10 Medtronic Vascular
9.10.1 Medtronic Vascular Drug Eluting Stents (DES) Basic Information
9.10.2 Medtronic Vascular Drug Eluting Stents (DES) Product Overview
9.10.3 Medtronic Vascular Drug Eluting Stents (DES) Product Market Performance
9.10.4 Medtronic Vascular Business Overview
9.10.5 Medtronic Vascular Recent Developments
9.11 MicroPort Medical
9.11.1 MicroPort Medical Drug Eluting Stents (DES) Basic Information
9.11.2 MicroPort Medical Drug Eluting Stents (DES) Product Overview
9.11.3 MicroPort Medical Drug Eluting Stents (DES) Product Market Performance
9.11.4 MicroPort Medical Business Overview
9.11.5 MicroPort Medical Recent Developments
9.12 MIV Therapeutics
9.12.1 MIV Therapeutics Drug Eluting Stents (DES) Basic Information
9.12.2 MIV Therapeutics Drug Eluting Stents (DES) Product Overview
9.12.3 MIV Therapeutics Drug Eluting Stents (DES) Product Market Performance
9.12.4 MIV Therapeutics Business Overview
9.12.5 MIV Therapeutics Recent Developments
9.13 Orbusneich
9.13.1 Orbusneich Drug Eluting Stents (DES) Basic Information
9.13.2 Orbusneich Drug Eluting Stents (DES) Product Overview
9.13.3 Orbusneich Drug Eluting Stents (DES) Product Market Performance
9.13.4 Orbusneich Business Overview
9.13.5 Orbusneich Recent Developments
9.14 Promed Medical
9.14.1 Promed Medical Drug Eluting Stents (DES) Basic Information
9.14.2 Promed Medical Drug Eluting Stents (DES) Product Overview
9.14.3 Promed Medical Drug Eluting Stents (DES) Product Market Performance
9.14.4 Promed Medical Business Overview
9.14.5 Promed Medical Recent Developments
9.15 Relisys Medical
9.15.1 Relisys Medical Drug Eluting Stents (DES) Basic Information
9.15.2 Relisys Medical Drug Eluting Stents (DES) Product Overview
9.15.3 Relisys Medical Drug Eluting Stents (DES) Product Market Performance
9.15.4 Relisys Medical Business Overview
9.15.5 Relisys Medical Recent Developments
9.16 Reva Medical
9.16.1 Reva Medical Drug Eluting Stents (DES) Basic Information
9.16.2 Reva Medical Drug Eluting Stents (DES) Product Overview
9.16.3 Reva Medical Drug Eluting Stents (DES) Product Market Performance
9.16.4 Reva Medical Business Overview
9.16.5 Reva Medical Recent Developments
9.17 Sahajanand
9.17.1 Sahajanand Drug Eluting Stents (DES) Basic Information
9.17.2 Sahajanand Drug Eluting Stents (DES) Product Overview
9.17.3 Sahajanand Drug Eluting Stents (DES) Product Market Performance
9.17.4 Sahajanand Business Overview
9.17.5 Sahajanand Recent Developments
9.18 Sino Medical
9.18.1 Sino Medical Drug Eluting Stents (DES) Basic Information
9.18.2 Sino Medical Drug Eluting Stents (DES) Product Overview
9.18.3 Sino Medical Drug Eluting Stents (DES) Product Market Performance
9.18.4 Sino Medical Business Overview
9.18.5 Sino Medical Recent Developments
9.19 Sorin
9.19.1 Sorin Drug Eluting Stents (DES) Basic Information
9.19.2 Sorin Drug Eluting Stents (DES) Product Overview
9.19.3 Sorin Drug Eluting Stents (DES) Product Market Performance
9.19.4 Sorin Business Overview
9.19.5 Sorin Recent Developments
9.20 Terumo Medical
9.20.1 Terumo Medical Drug Eluting Stents (DES) Basic Information
9.20.2 Terumo Medical Drug Eluting Stents (DES) Product Overview
9.20.3 Terumo Medical Drug Eluting Stents (DES) Product Market Performance
9.20.4 Terumo Medical Business Overview
9.20.5 Terumo Medical Recent Developments
10 DRUG ELUTING STENTS (DES) MARKET FORECAST BY REGION
10.1 Global Drug Eluting Stents (DES) Market Size Forecast
10.2 Global Drug Eluting Stents (DES) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Eluting Stents (DES) Market Size Forecast by Country
10.2.3 Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region
10.2.4 South America Drug Eluting Stents (DES) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Eluting Stents (DES) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug Eluting Stents (DES) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug Eluting Stents (DES) by Type (2025-2030)
11.1.2 Global Drug Eluting Stents (DES) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug Eluting Stents (DES) by Type (2025-2030)
11.2 Global Drug Eluting Stents (DES) Market Forecast by Application (2025-2030)
11.2.1 Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application
11.2.2 Global Drug Eluting Stents (DES) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Eluting Stents (DES) Market Size Comparison by Region (M USD)
Table 5. Global Drug Eluting Stents (DES) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Drug Eluting Stents (DES) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug Eluting Stents (DES) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Stents (DES) as of 2022)
Table 10. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug Eluting Stents (DES) Sales Sites and Area Served
Table 12. Manufacturers Drug Eluting Stents (DES) Product Type
Table 13. Global Drug Eluting Stents (DES) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug Eluting Stents (DES)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug Eluting Stents (DES) Market Challenges
Table 22. Global Drug Eluting Stents (DES) Sales by Type (K Units)
Table 23. Global Drug Eluting Stents (DES) Market Size by Type (M USD)
Table 24. Global Drug Eluting Stents (DES) Sales (K Units) by Type (2019-2024)
Table 25. Global Drug Eluting Stents (DES) Sales Market Share by Type (2019-2024)
Table 26. Global Drug Eluting Stents (DES) Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug Eluting Stents (DES) Market Size Share by Type (2019-2024)
Table 28. Global Drug Eluting Stents (DES) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Drug Eluting Stents (DES) Sales (K Units) by Application
Table 30. Global Drug Eluting Stents (DES) Market Size by Application
Table 31. Global Drug Eluting Stents (DES) Sales by Application (2019-2024) & (K Units)
Table 32. Global Drug Eluting Stents (DES) Sales Market Share by Application (2019-2024)
Table 33. Global Drug Eluting Stents (DES) Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug Eluting Stents (DES) Market Share by Application (2019-2024)
Table 35. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug Eluting Stents (DES) Sales by Region (2019-2024) & (K Units)
Table 37. Global Drug Eluting Stents (DES) Sales Market Share by Region (2019-2024)
Table 38. North America Drug Eluting Stents (DES) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Drug Eluting Stents (DES) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Drug Eluting Stents (DES) Sales by Region (2019-2024) & (K Units)
Table 41. South America Drug Eluting Stents (DES) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Drug Eluting Stents (DES) Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Vascular Drug Eluting Stents (DES) Basic Information
Table 44. Abbott Vascular Drug Eluting Stents (DES) Product Overview
Table 45. Abbott Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Vascular Business Overview
Table 47. Abbott Vascular Drug Eluting Stents (DES) SWOT Analysis
Table 48. Abbott Vascular Recent Developments
Table 49. Advantec Vascular Drug Eluting Stents (DES) Basic Information
Table 50. Advantec Vascular Drug Eluting Stents (DES) Product Overview
Table 51. Advantec Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Advantec Vascular Business Overview
Table 53. Advantec Vascular Drug Eluting Stents (DES) SWOT Analysis
Table 54. Advantec Vascular Recent Developments
Table 55. B.Braun Melsengen AG Drug Eluting Stents (DES) Basic Information
Table 56. B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
Table 57. B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. B.Braun Melsengen AG Drug Eluting Stents (DES) SWOT Analysis
Table 59. B.Braun Melsengen AG Business Overview
Table 60. B.Braun Melsengen AG Recent Developments
Table 61. Biosensors Drug Eluting Stents (DES) Basic Information
Table 62. Biosensors Drug Eluting Stents (DES) Product Overview
Table 63. Biosensors Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Biosensors Business Overview
Table 65. Biosensors Recent Developments
Table 66. Biotronik Drug Eluting Stents (DES) Basic Information
Table 67. Biotronik Drug Eluting Stents (DES) Product Overview
Table 68. Biotronik Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Biotronik Business Overview
Table 70. Biotronik Recent Developments
Table 71. Blue Medical Drug Eluting Stents (DES) Basic Information
Table 72. Blue Medical Drug Eluting Stents (DES) Product Overview
Table 73. Blue Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Blue Medical Business Overview
Table 75. Blue Medical Recent Developments
Table 76. Boston Scientific Drug Eluting Stents (DES) Basic Information
Table 77. Boston Scientific Drug Eluting Stents (DES) Product Overview
Table 78. Boston Scientific Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Boston Scientific Business Overview
Table 80. Boston Scientific Recent Developments
Table 81. DISA Vascular Drug Eluting Stents (DES) Basic Information
Table 82. DISA Vascular Drug Eluting Stents (DES) Product Overview
Table 83. DISA Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. DISA Vascular Business Overview
Table 85. DISA Vascular Recent Developments
Table 86. Essen Drug Eluting Stents (DES) Basic Information
Table 87. Essen Drug Eluting Stents (DES) Product Overview
Table 88. Essen Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Essen Business Overview
Table 90. Essen Recent Developments
Table 91. Medtronic Vascular Drug Eluting Stents (DES) Basic Information
Table 92. Medtronic Vascular Drug Eluting Stents (DES) Product Overview
Table 93. Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Medtronic Vascular Business Overview
Table 95. Medtronic Vascular Recent Developments
Table 96. MicroPort Medical Drug Eluting Stents (DES) Basic Information
Table 97. MicroPort Medical Drug Eluting Stents (DES) Product Overview
Table 98. MicroPort Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. MicroPort Medical Business Overview
Table 100. MicroPort Medical Recent Developments
Table 101. MIV Therapeutics Drug Eluting Stents (DES) Basic Information
Table 102. MIV Therapeutics Drug Eluting Stents (DES) Product Overview
Table 103. MIV Therapeutics Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. MIV Therapeutics Business Overview
Table 105. MIV Therapeutics Recent Developments
Table 106. Orbusneich Drug Eluting Stents (DES) Basic Information
Table 107. Orbusneich Drug Eluting Stents (DES) Product Overview
Table 108. Orbusneich Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Orbusneich Business Overview
Table 110. Orbusneich Recent Developments
Table 111. Promed Medical Drug Eluting Stents (DES) Basic Information
Table 112. Promed Medical Drug Eluting Stents (DES) Product Overview
Table 113. Promed Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Promed Medical Business Overview
Table 115. Promed Medical Recent Developments
Table 116. Relisys Medical Drug Eluting Stents (DES) Basic Information
Table 117. Relisys Medical Drug Eluting Stents (DES) Product Overview
Table 118. Relisys Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Relisys Medical Business Overview
Table 120. Relisys Medical Recent Developments
Table 121. Reva Medical Drug Eluting Stents (DES) Basic Information
Table 122. Reva Medical Drug Eluting Stents (DES) Product Overview
Table 123. Reva Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Reva Medical Business Overview
Table 125. Reva Medical Recent Developments
Table 126. Sahajanand Drug Eluting Stents (DES) Basic Information
Table 127. Sahajanand Drug Eluting Stents (DES) Product Overview
Table 128. Sahajanand Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Sahajanand Business Overview
Table 130. Sahajanand Recent Developments
Table 131. Sino Medical Drug Eluting Stents (DES) Basic Information
Table 132. Sino Medical Drug Eluting Stents (DES) Product Overview
Table 133. Sino Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Sino Medical Business Overview
Table 135. Sino Medical Recent Developments
Table 136. Sorin Drug Eluting Stents (DES) Basic Information
Table 137. Sorin Drug Eluting Stents (DES) Product Overview
Table 138. Sorin Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Sorin Business Overview
Table 140. Sorin Recent Developments
Table 141. Terumo Medical Drug Eluting Stents (DES) Basic Information
Table 142. Terumo Medical Drug Eluting Stents (DES) Product Overview
Table 143. Terumo Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Terumo Medical Business Overview
Table 145. Terumo Medical Recent Developments
Table 146. Global Drug Eluting Stents (DES) Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Drug Eluting Stents (DES) Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Drug Eluting Stents (DES) Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Drug Eluting Stents (DES) Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Drug Eluting Stents (DES) Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Drug Eluting Stents (DES) Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Drug Eluting Stents (DES) Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Drug Eluting Stents (DES) Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Drug Eluting Stents (DES) Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Drug Eluting Stents (DES) Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Drug Eluting Stents (DES) Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Drug Eluting Stents (DES) Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Drug Eluting Stents (DES) Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Drug Eluting Stents (DES) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Drug Eluting Stents (DES) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Eluting Stents (DES) Market Size Comparison by Region (M USD)
Table 5. Global Drug Eluting Stents (DES) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Drug Eluting Stents (DES) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug Eluting Stents (DES) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Stents (DES) as of 2022)
Table 10. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug Eluting Stents (DES) Sales Sites and Area Served
Table 12. Manufacturers Drug Eluting Stents (DES) Product Type
Table 13. Global Drug Eluting Stents (DES) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug Eluting Stents (DES)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug Eluting Stents (DES) Market Challenges
Table 22. Global Drug Eluting Stents (DES) Sales by Type (K Units)
Table 23. Global Drug Eluting Stents (DES) Market Size by Type (M USD)
Table 24. Global Drug Eluting Stents (DES) Sales (K Units) by Type (2019-2024)
Table 25. Global Drug Eluting Stents (DES) Sales Market Share by Type (2019-2024)
Table 26. Global Drug Eluting Stents (DES) Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug Eluting Stents (DES) Market Size Share by Type (2019-2024)
Table 28. Global Drug Eluting Stents (DES) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Drug Eluting Stents (DES) Sales (K Units) by Application
Table 30. Global Drug Eluting Stents (DES) Market Size by Application
Table 31. Global Drug Eluting Stents (DES) Sales by Application (2019-2024) & (K Units)
Table 32. Global Drug Eluting Stents (DES) Sales Market Share by Application (2019-2024)
Table 33. Global Drug Eluting Stents (DES) Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug Eluting Stents (DES) Market Share by Application (2019-2024)
Table 35. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug Eluting Stents (DES) Sales by Region (2019-2024) & (K Units)
Table 37. Global Drug Eluting Stents (DES) Sales Market Share by Region (2019-2024)
Table 38. North America Drug Eluting Stents (DES) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Drug Eluting Stents (DES) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Drug Eluting Stents (DES) Sales by Region (2019-2024) & (K Units)
Table 41. South America Drug Eluting Stents (DES) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Drug Eluting Stents (DES) Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Vascular Drug Eluting Stents (DES) Basic Information
Table 44. Abbott Vascular Drug Eluting Stents (DES) Product Overview
Table 45. Abbott Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Vascular Business Overview
Table 47. Abbott Vascular Drug Eluting Stents (DES) SWOT Analysis
Table 48. Abbott Vascular Recent Developments
Table 49. Advantec Vascular Drug Eluting Stents (DES) Basic Information
Table 50. Advantec Vascular Drug Eluting Stents (DES) Product Overview
Table 51. Advantec Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Advantec Vascular Business Overview
Table 53. Advantec Vascular Drug Eluting Stents (DES) SWOT Analysis
Table 54. Advantec Vascular Recent Developments
Table 55. B.Braun Melsengen AG Drug Eluting Stents (DES) Basic Information
Table 56. B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
Table 57. B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. B.Braun Melsengen AG Drug Eluting Stents (DES) SWOT Analysis
Table 59. B.Braun Melsengen AG Business Overview
Table 60. B.Braun Melsengen AG Recent Developments
Table 61. Biosensors Drug Eluting Stents (DES) Basic Information
Table 62. Biosensors Drug Eluting Stents (DES) Product Overview
Table 63. Biosensors Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Biosensors Business Overview
Table 65. Biosensors Recent Developments
Table 66. Biotronik Drug Eluting Stents (DES) Basic Information
Table 67. Biotronik Drug Eluting Stents (DES) Product Overview
Table 68. Biotronik Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Biotronik Business Overview
Table 70. Biotronik Recent Developments
Table 71. Blue Medical Drug Eluting Stents (DES) Basic Information
Table 72. Blue Medical Drug Eluting Stents (DES) Product Overview
Table 73. Blue Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Blue Medical Business Overview
Table 75. Blue Medical Recent Developments
Table 76. Boston Scientific Drug Eluting Stents (DES) Basic Information
Table 77. Boston Scientific Drug Eluting Stents (DES) Product Overview
Table 78. Boston Scientific Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Boston Scientific Business Overview
Table 80. Boston Scientific Recent Developments
Table 81. DISA Vascular Drug Eluting Stents (DES) Basic Information
Table 82. DISA Vascular Drug Eluting Stents (DES) Product Overview
Table 83. DISA Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. DISA Vascular Business Overview
Table 85. DISA Vascular Recent Developments
Table 86. Essen Drug Eluting Stents (DES) Basic Information
Table 87. Essen Drug Eluting Stents (DES) Product Overview
Table 88. Essen Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Essen Business Overview
Table 90. Essen Recent Developments
Table 91. Medtronic Vascular Drug Eluting Stents (DES) Basic Information
Table 92. Medtronic Vascular Drug Eluting Stents (DES) Product Overview
Table 93. Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Medtronic Vascular Business Overview
Table 95. Medtronic Vascular Recent Developments
Table 96. MicroPort Medical Drug Eluting Stents (DES) Basic Information
Table 97. MicroPort Medical Drug Eluting Stents (DES) Product Overview
Table 98. MicroPort Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. MicroPort Medical Business Overview
Table 100. MicroPort Medical Recent Developments
Table 101. MIV Therapeutics Drug Eluting Stents (DES) Basic Information
Table 102. MIV Therapeutics Drug Eluting Stents (DES) Product Overview
Table 103. MIV Therapeutics Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. MIV Therapeutics Business Overview
Table 105. MIV Therapeutics Recent Developments
Table 106. Orbusneich Drug Eluting Stents (DES) Basic Information
Table 107. Orbusneich Drug Eluting Stents (DES) Product Overview
Table 108. Orbusneich Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Orbusneich Business Overview
Table 110. Orbusneich Recent Developments
Table 111. Promed Medical Drug Eluting Stents (DES) Basic Information
Table 112. Promed Medical Drug Eluting Stents (DES) Product Overview
Table 113. Promed Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Promed Medical Business Overview
Table 115. Promed Medical Recent Developments
Table 116. Relisys Medical Drug Eluting Stents (DES) Basic Information
Table 117. Relisys Medical Drug Eluting Stents (DES) Product Overview
Table 118. Relisys Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Relisys Medical Business Overview
Table 120. Relisys Medical Recent Developments
Table 121. Reva Medical Drug Eluting Stents (DES) Basic Information
Table 122. Reva Medical Drug Eluting Stents (DES) Product Overview
Table 123. Reva Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Reva Medical Business Overview
Table 125. Reva Medical Recent Developments
Table 126. Sahajanand Drug Eluting Stents (DES) Basic Information
Table 127. Sahajanand Drug Eluting Stents (DES) Product Overview
Table 128. Sahajanand Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Sahajanand Business Overview
Table 130. Sahajanand Recent Developments
Table 131. Sino Medical Drug Eluting Stents (DES) Basic Information
Table 132. Sino Medical Drug Eluting Stents (DES) Product Overview
Table 133. Sino Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Sino Medical Business Overview
Table 135. Sino Medical Recent Developments
Table 136. Sorin Drug Eluting Stents (DES) Basic Information
Table 137. Sorin Drug Eluting Stents (DES) Product Overview
Table 138. Sorin Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Sorin Business Overview
Table 140. Sorin Recent Developments
Table 141. Terumo Medical Drug Eluting Stents (DES) Basic Information
Table 142. Terumo Medical Drug Eluting Stents (DES) Product Overview
Table 143. Terumo Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Terumo Medical Business Overview
Table 145. Terumo Medical Recent Developments
Table 146. Global Drug Eluting Stents (DES) Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Drug Eluting Stents (DES) Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Drug Eluting Stents (DES) Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Drug Eluting Stents (DES) Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Drug Eluting Stents (DES) Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Drug Eluting Stents (DES) Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Drug Eluting Stents (DES) Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Drug Eluting Stents (DES) Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Drug Eluting Stents (DES) Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Drug Eluting Stents (DES) Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Drug Eluting Stents (DES) Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Drug Eluting Stents (DES) Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Drug Eluting Stents (DES) Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Drug Eluting Stents (DES) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Drug Eluting Stents (DES) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Drug Eluting Stents (DES)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Eluting Stents (DES) Market Size (M USD), 2019-2030
Figure 5. Global Drug Eluting Stents (DES) Market Size (M USD) (2019-2030)
Figure 6. Global Drug Eluting Stents (DES) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug Eluting Stents (DES) Market Size by Country (M USD)
Figure 11. Drug Eluting Stents (DES) Sales Share by Manufacturers in 2023
Figure 12. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers in 2023
Figure 13. Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug Eluting Stents (DES) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug Eluting Stents (DES) Market Share by Type
Figure 18. Sales Market Share of Drug Eluting Stents (DES) by Type (2019-2024)
Figure 19. Sales Market Share of Drug Eluting Stents (DES) by Type in 2023
Figure 20. Market Size Share of Drug Eluting Stents (DES) by Type (2019-2024)
Figure 21. Market Size Market Share of Drug Eluting Stents (DES) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug Eluting Stents (DES) Market Share by Application
Figure 24. Global Drug Eluting Stents (DES) Sales Market Share by Application (2019-2024)
Figure 25. Global Drug Eluting Stents (DES) Sales Market Share by Application in 2023
Figure 26. Global Drug Eluting Stents (DES) Market Share by Application (2019-2024)
Figure 27. Global Drug Eluting Stents (DES) Market Share by Application in 2023
Figure 28. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug Eluting Stents (DES) Sales Market Share by Region (2019-2024)
Figure 30. North America Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Drug Eluting Stents (DES) Sales Market Share by Country in 2023
Figure 32. U.S. Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Drug Eluting Stents (DES) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Drug Eluting Stents (DES) Sales Market Share by Country in 2023
Figure 37. Germany Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Drug Eluting Stents (DES) Sales Market Share by Region in 2023
Figure 44. China Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 50. South America Drug Eluting Stents (DES) Sales Market Share by Country in 2023
Figure 51. Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Drug Eluting Stents (DES) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Drug Eluting Stents (DES) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Drug Eluting Stents (DES) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Drug Eluting Stents (DES) Market Share Forecast by Type (2025-2030)
Figure 65. Global Drug Eluting Stents (DES) Sales Forecast by Application (2025-2030)
Figure 66. Global Drug Eluting Stents (DES) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Drug Eluting Stents (DES)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Eluting Stents (DES) Market Size (M USD), 2019-2030
Figure 5. Global Drug Eluting Stents (DES) Market Size (M USD) (2019-2030)
Figure 6. Global Drug Eluting Stents (DES) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug Eluting Stents (DES) Market Size by Country (M USD)
Figure 11. Drug Eluting Stents (DES) Sales Share by Manufacturers in 2023
Figure 12. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers in 2023
Figure 13. Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug Eluting Stents (DES) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug Eluting Stents (DES) Market Share by Type
Figure 18. Sales Market Share of Drug Eluting Stents (DES) by Type (2019-2024)
Figure 19. Sales Market Share of Drug Eluting Stents (DES) by Type in 2023
Figure 20. Market Size Share of Drug Eluting Stents (DES) by Type (2019-2024)
Figure 21. Market Size Market Share of Drug Eluting Stents (DES) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug Eluting Stents (DES) Market Share by Application
Figure 24. Global Drug Eluting Stents (DES) Sales Market Share by Application (2019-2024)
Figure 25. Global Drug Eluting Stents (DES) Sales Market Share by Application in 2023
Figure 26. Global Drug Eluting Stents (DES) Market Share by Application (2019-2024)
Figure 27. Global Drug Eluting Stents (DES) Market Share by Application in 2023
Figure 28. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug Eluting Stents (DES) Sales Market Share by Region (2019-2024)
Figure 30. North America Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Drug Eluting Stents (DES) Sales Market Share by Country in 2023
Figure 32. U.S. Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Drug Eluting Stents (DES) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Drug Eluting Stents (DES) Sales Market Share by Country in 2023
Figure 37. Germany Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Drug Eluting Stents (DES) Sales Market Share by Region in 2023
Figure 44. China Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 50. South America Drug Eluting Stents (DES) Sales Market Share by Country in 2023
Figure 51. Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Drug Eluting Stents (DES) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Drug Eluting Stents (DES) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Drug Eluting Stents (DES) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Drug Eluting Stents (DES) Market Share Forecast by Type (2025-2030)
Figure 65. Global Drug Eluting Stents (DES) Sales Forecast by Application (2025-2030)
Figure 66. Global Drug Eluting Stents (DES) Market Share Forecast by Application (2025-2030)
